3389-0331 Screening compound: 8-methoxy-2-(4-methoxyphenyl)-4,4-dimethyl-1H,2H,4H,5H-[1,2]thiazolo[5,4-c]quinoline-1-thione

3389-0331 Screening compound: 8-methoxy-2-(4-methoxyphenyl)-4,4-dimethyl-1H,2H,4H,5H-[1,2]thiazolo[5,4-c]quinoline-1-thione
3389-0331 Screening compound: 8-methoxy-2-(4-methoxyphenyl)-4,4-dimethyl-1H,2H,4H,5H-[1,2]thiazolo[5,4-c]quinoline-1-thione alternative view

Chemical Structure Depiction of ChemDiv screening compound 3389-0331
8-methoxy-2-(4-methoxyphenyl)-4,4-dimethyl-1H,2H,4H,5H-[1,2]thiazolo[5,4-c]quinoline-1-thione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3389-0331

Molecular Formula

C20H20N2O2S2 (C20 H20 N2 O2 S2)

Compound Name

8-methoxy-2-(4-methoxyphenyl)-4,4-dimethyl-1H,2H,4H,5H-[1,2]thiazolo[5,4-c]quinoline-1-thione

IUPAC name

8-methoxy-2-(4-methoxyphenyl)-44-dimethyl-1H2H4H5H-[12]thiazolo[54-c]quinoline-1-thione

SMILES

CC1(C)Nc(ccc(OC)c2)c2C(C2=S)=C1SN2c(cc1)ccc1OC

InChI

InChI=1S/C20H20N2O2S2/c1-20(2)18-17(15-11-14(24-4)9-10-16(15)21-20)19(25)22(26-18)12-5-7-13(23-3)8-6-12/h5-11,21H,1-4H3

InChI Key

KYTVAXWJBZJEFB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00808933

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

384.52

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

5.117

Distribution Coefficient, logD

3.690

Water Solubility, LogSw

-5.12

Polar Surface Area

29.793

Acid Dissociation Constant (pKa)

17.72

Base Dissociation Constant (pKb)

-1.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

3389-0331 in Drug Discovery

Included in Screening Libraries

Antiviral Annotated Library (21441 compounds)

CNS targets activity set (6557 compounds)

Human GPCR Annotated Library (5539 compounds)

Human Transcription Factors Annotated Library (5098 compounds)

KRAS-Targeted Library (16000 compounds)

Akt-Targeted Library (14764 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with 3389-0331 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3389-0331?
Check Price and Availability of 3389-0331, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3389-0331 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3389-0331
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3389-0331
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3389-0331 available by request